DMED
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
DMED
Industry:
Biopharma Medical Pharmaceutical
Founded:
2016-08-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.dmedglobal.com
Total Employee:
11+
Status:
Active
Total Funding:
214 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Euro Microsoft Azure DNS ASP.NET IIS Pound Sterling
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Encore Dermatology
Encore is a dermatology company that provides prescription therapies and medical devices to dermatologists.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Tarsier Pharma
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.
VetSource
VetSource is a pharmaceuticals company providing pet care medication and vaccination services.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-28 | Clinipace | Clinipace acquired by dMed | N/A |
Investors List
SpringHill Management
SpringHill Management investment in Series C - dMed
Rock Springs Capital
Rock Springs Capital investment in Series C - dMed
E-Fund
E-Fund investment in Series C - dMed
Sequoia Capital China
Sequoia Capital China investment in Series C - dMed
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals investment in Series C - dMed
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - dMed
Superstring Capital
Superstring Capital investment in Series C - dMed
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - dMed
E-Fund
E-Fund investment in Series C - dMed
Kaiser Permanente
Kaiser Permanente investment in Series C - dMed
Official Site Inspections
http://www.dmedglobal.com Semrush global rank: 6.76 M Semrush visits lastest month: 816
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
